Profile avatar
thebeehive.bsky.social
Engelhardt Research Group at Stanford University and Gladstone Institutes. Statistical genomics, live-cell imaging, wearable data, cancer immunology, reproductive health.
23 posts 265 followers 581 following
Active Commenter
comment in response to post
Me three!
comment in response to post
Feedback welcome! And please play with these data! There is a lot more signal there. Thank you to @bioimagearchive.bsky.social for hosting these Incucyte image data -- this is a new thing for them, and they have been so kind in working through the details of submission (link coming soon!)! 🎉
comment in response to post
Try out Caliban and Occident on your own Incucyte data! More phenotypes and analyses added regularly. github.com/vanvalenlab/... github.com/bee-hive/occ...
comment in response to post
With five new collaborations in the works, and a paper characterizing the differences using explainable AI already accepted as an oral presentation at #PSB2025 (lead by high school senior Marcus Blennemann), look for future work in this space! www.biorxiv.org/content/10.1...
comment in response to post
In summary, we found that, compared to the SH KO control condition, TCR T cells with the RASA2 KO have a longer dwell time and cripple cancer cells more effectively this way, whereas TCR T cells with the CUL5 KO proliferated more frequently upon activation, adding more T cells to the fight.
comment in response to post
With a Markov model, we deconvolved when, in frame t-1, there is one cancer cell and one T cell in a window, and in frame t there is one cancer cell and two T cells. We were able to quantify how often this doubling of T cells attacking a cancer cell was due to proliferation or due to recruitment.
comment in response to post
Most thrilling is that we can identify active T cells based on relative cell size and morphology, and watch T cells activate (differentially based on condition) after interacting with cancer cells.
comment in response to post
Even more exciting, the speed of cancer cells decreased after interactions with T cells, as did their overall size (indicating stress).
comment in response to post
While the # of T cell--cancer cell interactions increased similarly, these interactions & their effects were modulated by the CRISPR KOs. E.g., the time a T cell remained attached to a cancer cell (as estimated by a negative binomial and Markov model separately) was highest in RASA2 KO T cells.
comment in response to post
Cancer cell and T cell morphology changes dramatically depending on state. These changes are visible in the brightfield imaging – active interacting T cells are larger and change to less circular shapes. Cancer cell begin to aggregate together when interacting with T cells.
comment in response to post
We found that the number of T cells attached to cancer cells reduces the likelihood that the cancer cell will proliferate, with the beneficial KO T cells having greater effects on proliferation reduction.
comment in response to post
We can study differences in cancer cell division events (lower in beneficial KO T cells) and average T cell speed (faster in beneficial KO T cells).
comment in response to post
We found that T cell proliferation increased in the two beneficial KO T cells, in the CUL5 KO T cells in particular.
comment in response to post
With the masked, tracked cells, we went to work to develop Occident. We were curious how well the RFP markers captured cancer cell number; we found that RFP lags as a proxy for cancer cell numbers.
comment in response to post
Then, the Van Valen Lab developed Caliban to segment and track each cell (green are T cells, red are cancer cells, white are detritus).
comment in response to post
Each well was imaged every 4 minutes at 10X magnification on Sartorius Incucyte for 72 hrs. Images include brightfield, RFP (cancer cell nuclei) channels.
comment in response to post
We teamed up with Alex Marson and Julia Carnevale’s Labs, who imaged TCR T cells co-cultured with RFP+ A375 tumor cells 3 ways: Safe harbor knockout (SH KO; control), RASA2 KO (Carnevale et al., 2022), CUL5 KO (Liao et al., 2024).
comment in response to post
…and amazing pack hunting behaviors of the modified T cells:
comment in response to post
…cancer cell death, which is quite rare in much of these data...
comment in response to post
A lot of interesting signal is left on the cutting room floor. For example, proliferation (rates) in cancer cells...
comment in response to post
Incucyte live cell imaging is ubiquitous, but from this complex data cancer immunologists typically plot one thing: the number of red pixels in the well, which is a proxy for the cancer cell coverage (RFP marks cancer cell nuclei). From [Carnevale et al. 2022]: